EncorVita Health acquires HerMD-linked menopause education assets to bring midlife care into aesthetic clinics
EncorVita’s strategy centres on embedding structured menopause education and clinical frameworks into existing settings.
Education platform EncorVita Health has acquired menopause and sexual health education and clinical assets from Eterna, Inc., in a deal that aims to move structured menopause care into medical aesthetic clinics across the US.
The assets include intellectual property originally developed through more than a decade of clinical practice at multi-state women’s health clinics run by HerMD - which was itself acquired by Joi + Blokes in late 2025. The assets comprise a comprehensive education platform and a suite of clinical resources designed to support clinicians in integrating perimenopause, menopause and sexual health care into practice. EncorVita said the acquisition will allow it to scale those clinical frameworks and education tools across aesthetic and specialty providers.
The move places menopause care directly inside a fast-growing segment of private-pay healthcare — aesthetic clinics — where many midlife women already seek trusted services.
Bringing care to where women already are
More than 50 million women in the US are entering perimenopause and menopause, yet access to clinicians formally trained in menopause and sexual health remains limited. Specialist services are unevenly distributed, and many OB-GYNs report limited formal training in menopause medicine.
At the same time, aesthetic clinics have expanded beyond injectables and laser treatments into broader “wellness” and longevity offerings. Hormone therapy and sexual health services are increasingly appearing on menus — but without consistent education standards or clinical frameworks.
EncorVita’s strategy centres on embedding structured menopause education and clinical frameworks into these existing settings.
“Our goal is to build the premier women’s health education and resource platform — one that ensures far more women of perimenopausal age receive the informed, evidence-based care and provider support they are actively seeking and deserve,” said Amber Edwards, founder and chief executive of EncorVita Health.
Edwards said the acquisition provides a clinical foundation that can be scaled across aesthetic and specialty clinics, enabling them to expand services in menopause and sexual health.
The company describes itself as a provider-facing education and enablement platform. Rather than delivering patient care directly, it offers digital education, clinical protocols and implementation support to help aesthetic and specialty clinics expand into menopause and sexual health care.
HerMD-linked clinical frameworks
The intellectual property included in the transaction was originally developed through clinical operations at HerMD, a multi-state women’s health clinic network focused on menopause and sexual health. According to the announcement, the clinical frameworks are informed by nationally recognised and published guidelines, alongside insights from more than ten years of clinical experience.
Komel Caruso, chief executive of Eterna, Inc., said:
“Over the past decade, we helped build and refine a clinically rigorous model for menopause and sexual health care. EncorVita represents an opportunity to expand that knowledge empowering more providers and reaching exponentially more women.”
The announcement does not disclose financial terms of the acquisition.
Expanding into aesthetics
The acquisition underscores a broader shift in how and where menopause care is being delivered. Private-pay models are increasingly filling gaps left by traditional healthcare systems, particularly in areas such as hormone therapy and sexual health that have historically been underprioritised.
Embedding structured menopause education into aesthetic clinics could expand access by leveraging existing provider networks and patient relationships. But it also places significant weight on training quality, adherence to evidence-based guidelines and ongoing clinical oversight.
The company describes the acquisition as a “foundational step” in its long-term strategy to build a comprehensive women’s health platform integrating education, clinical resources and curated solutions for providers.
For the women’s health sector, the deal is notable not just for the assets involved, but for what it represents: menopause care moving decisively beyond specialist clinics and into the mainstream of private, consumer-facing healthcare. How that shift is implemented — and regulated — will likely shape the next phase of midlife care delivery.